Stem Cell Therapy Market Outlook, Trends And Future Opportunities (2024-2031)

Download FREE Sample Customize As Per Need Buy Now
  1. home
  2. Report Store
  3. Stem Cell Therapy Market

Stem Cell Therapy Market Outlook, Trends And Future Opportunities (2024-2031)

Stem Cell Therapy Market, By Source (Embryonic Stem Cells Induced Pluripotent Stem Cells Adult Stem Cells Umbilical Cord Stem Cells Others), By Type (Allogeneic Stem Cell Therapy Autologous Stem Cell Therapy Syngeneic Stem Cell Therapy), By Application (Musculoskeletal Disorders Cardiovascular Diseases Neurological Disorders Autoimmune Diseases Oncology Wounds and Injuries Others), By Technology (Cell Acquisition Cell Production Cryopreservation Expansion and Sub-Culture Others), By End User (Hospitals and Clinics Academic and Research Institutes Biotechnology and Pharmaceutical Companies Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Apr 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA141
  • Region: Global
  • Format: PDF/EXCEL
Press Release: Stem Cell Therapy Market is Forecasted to Hit US$ 24.1 Bn By 2031 | CAGR 12.8%

Table Of Contents

  • Chapter 1. Research Methodology and Scope
    • Market Segmentation and Scope
    • Regional Coverage
    • Objectives
    • Research Methodology
  • Chapter 2. Executive Summary
    • Market Landscape
    • Market Size & Forecast
    • Competitive Landscape
  • Chapter 3. Stem Cell Therapy Market: By Source Market Trends, Size, and Future Outlook
    • By Source Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Source Definitions, Technology Landscape
    • By Source Market Drivers
      • Product Launches
      • Technology Launches
    • By Source Market Restraints
  • Chapter 4. Stem Cell Therapy Market: By Type Market Trends, Size, and Future Outlook
    • By Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Type Definitions, Technology Landscape
    • By Type Market Drivers
      • Product Launches
      • Technology Launches
    • By Type Market Restraints
  • Chapter 5. Stem Cell Therapy Market: By Application Market Trends, Size, and Future Outlook
    • By Application Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Application Definitions, Technology Landscape
    • By Application Market Drivers
      • Product Launches
      • Technology Launches
    • By Application Market Restraints
  • Chapter 6. Stem Cell Therapy Market: By Technology Market Trends, Size, and Future Outlook
    • By Technology Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Technology Definitions, Technology Landscape
    • By Technology Market Drivers
      • Product Launches
      • Technology Launches
    • By Technology Market Restraints
  • Chapter 7. Stem Cell Therapy Market: By End User Market Trends, Size, and Future Outlook
    • By End User Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By End User Definitions, Technology Landscape
    • By End User Market Drivers
      • Product Launches
      • Technology Launches
    • By End User Market Restraints
  • Chapter 8. Stem Cell Therapy Market: Regional Market Trends, Size, and Future Outlook
    • North America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Europe
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Asia Pacific
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Latin America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Middle East, and Africa
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
  • Chapter 9. Stem Cell Therapy Market: Competitive Landscape
    • Mesoblast Limited
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Osiris Therapeutics, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • MEDIPOST Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Holostem Terapie Avanzate S.r.l.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Pluristem Therapeutics Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Cytori Therapeutics, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Celgene Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Vericel Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Gamida Cell Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Athersys, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Saneron CCEL Therapeutics, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Fibrocell Science, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • BrainStorm Cell Therapeutics Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • TiGenix NV
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Caladrius Biosciences, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Cryo-Cell International, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Lonza Group Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Anterogen Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • STEMCELL Technologies Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Biotime, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
  • Research Methodology
    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases
  • Appendix
    • About Us

Frequently Asked Questions

The current market size of the Stem Cell Therapy industry is USD 9.2 billion.

Increasing prevalence of chronic diseases, rising demand for personalized medicine, advancements in stem cell research, and growing investments in regenerative medicine.

Ethical concerns and regulatory hurdles, high cost of stem cell therapies, lack of standardized manufacturing processes, and limited reimbursement and insurance coverage.

The adult stem cell segment is the leading component segment in the Stem Cell Therapy Market due to its wide applications and reduced ethical concerns.

Mesoblast Limited, Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Holostem Terapie Avanzate S.r.l., Pluristem Therapeutics Inc., Cytori Therapeutics, Inc., Celgene Corporation, Vericel Corporation, Gamida Cell Ltd., and Athersys, Inc.

The North America region is expected to lead the Stem Cell Therapy Market, with a market size of USD 8.3 billion in 2024 and a CAGR of 12.5% during the forecast period.

Increasing prevalence of chronic diseases, rising demand for personalized medicine, advancements in stem cell research, growing investments in regenerative medicine, aging population, and technological advancements in cell culture and manufacturing processes.
Download FREE Sample Buy Now